pargyline and elacridar

pargyline has been researched along with elacridar in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chan, CF; Chan, KF; Chan, TH; Chong, TC; Chow, LMC; Chow, TS; Cui, J; Law, MC; Liu, Z; Wong, ILK; Zhu, X1

Other Studies

1 other study(ies) available for pargyline and elacridar

ArticleYear
Flavonoid Monomers as Potent, Nontoxic, and Selective Modulators of the Breast Cancer Resistance Protein (ABCG2).
    Journal of medicinal chemistry, 2021, 10-14, Volume: 64, Issue:19

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonoids; HEK293 Cells; Humans; Mitoxantrone; Neoplasm Proteins; Structure-Activity Relationship; Substrate Specificity

2021